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an active role in immune homeostasis by keeping at bay the intestinal microbiota, and they also participate in the modulation of the immune system. [2] [3] [4] [5] However, whether changes in epithelial cells affect gut Treg cells is still unknown.
The Treg cells differentiate into diverse effector subsets that can have organ-specific properties. 6, 7 Several effector Treg subsets have been described in the mouse gut, including Helios À RORct + Treg cells, which develop in response to microbial factors, and the GATA3 + Treg subset that arises independently of the microbiota (reviewed in ref. 8) . In addition to the expression of distinctive transcription factors, Treg subpopulations can express surface receptors such as KLRG1, which can be found on a significant proportion of gut Treg cells and is considered a marker of terminally differentiated Treg cells. 9, 10 In humans, accumulation of effector Treg cells, but not of other FOXP3 + populations, is associated with a worse prognosis in colorectal cancer, 11 and two recent studies have confirmed that human tumour-infiltrating Treg cells have a specific distinct phenotype. 12, 13 Here we use mouse models to examine whether tumour-related alterations of epithelial cells can per se affect intestinal Treg populations. We have focused on Ecadherin, a key epithelial cell adhesion molecule that also affects intracellular signalling. We used a mouse model of cell-specific cadherin switch in which E-cadherin is replaced by its homologue N-cadherin in the intestinal epithelium, 14 mimicking the cadherin switch that takes place during epithelial to mesenchymal transition, a key step in tumour progression. We found that mice with Ecadherin-deficient epithelium present with a striking expansion of effector-like KLRG1 + GATA3 + Foxp3 + cells. Using additional genetically modified mouse models, we linked KLRG1 + GATA3 + Treg cell accumulation to increased epithelial b-catenin signals, which promote intestinal interleukin-33 (IL-33) expression. Spontaneous intestinal tumours from mice with increased b-catenin signals also presented strong specific accumulation of KLRG1 + GATA3 + Treg cells. Our data highlight an unappreciated role for intestinal epithelial cells in controlling the size of the gut Treg cell compartment. Given the role of Treg cells in maintaining an immunosuppressive environment in tumours, the axis linking epithelial b-catenin to KLRG1
+ GATA3 + Treg cell accumulation could be an interesting therapeutic target. min/+ mice on a C57BL/6 background were kept and bred under specific pathogen-free conditions in filter-top cages at the University of Gothenburg and analysed between 18 and 21 weeks of age. The study was approved by the animal ethics committee at the University of Gothenburg.
Materials and methods

Mouse strains
Isolation of leucocytes from the lamina propria and epithelial cells
Leucocytes from the lamina propria were isolated as described elsewhere. 17, 18 Briefly, small intestine and colon were removed and cleaned. Samples (around 5 mm long) were removed for histology, and the rest of the colon was used for lymphocyte isolation. For young Cdh1 DIEC mice and littermate controls, the whole small intestine was used for lymphocyte isolation after removal of samples for histology. For IL-10-deficient and dextran sulphate-sodium (DSS) -treated mice and controls, the distal small intestine was used for lymphocyte isolation. The proximal and distal parts of Ctnnb1 (Ex3)fl/+ Lgr5-EGFP-IRES-ERT2:Cre + mice and controls were used for isolation as indicated. For APC min/+ and control mice, the entire small intestine was used for isolation. After washing with ice-cold PBS, intestines were washed twice in Hanks' balanced salt solution (HBSS) containing 5 mM EDTA and 10 mM HEPES at 37°to remove the epithelial cell layer. The tissue was then minced finely and digested three times in HBSS containing Dispase (5 units/ml; BD Biosciences, Franklin Lakes, NJ, USA), Collagenase IV (0Á5 mg/ml; Worthington, Lakewood, NJ) and DNaseA (0Á5 mg/ml; AppliChem, Darmstadt, Germany), at 37°with constant shaking. Supernatants were collected and lymphocytes were enriched after a gradient centrifugation using buffered Percoll (GE Healthcare, Freiburg, Germany).
DSS-colitis
Induction of colitis using DSS was done as previously described. 19 Briefly, animals were given 3% DSS (MP Biomedicals, Santa Ana, CA) in the drinking water for 8 days. Weight loss was monitored as a sign of disease progression. Mice were killed at day 8 for analysis and the establishment of colitis was checked by macroscopic signs (swollen, pale colon).
Antibodies and flow cytometry
Single-cell suspensions were stained in 96-well plates (10 6 cells per well). The following conjugated antibodies were purchased from eBioscience (Affymetrix, Inc., Santa Clara, CA, USA): TCR-b (H57-597), CD3 (145-2C11), CD4 (GK 1..5), KLRG1 (2F1), CD103 (2E7), CD44 (IM7), CD45RB (C363.16A), CD62L (MEL-14), CD69 (H1.2F3), CD45.1 (A20), CD45.2 (104), CD25 (PC61.5), Foxp3 (FJK-16s), GATA3 (TWAJ), Tbet (3C8), Rorc (B2D), Helios (22F6), IRF4 (3E4), Ki67 (20Raj1), Nur77 (12.14) and CTLA4 (UC10-4B9). Anti-IL-33Ra antibody (DIH9) was purchased from Biolegend (San Diego, CA, USA). Intracellular staining was performed with the eBioscience permeabilization and fixation kit. Anti-Bcl-2 (3F11) was purchased from BD Biosciences. Dead cells were excluded by staining with Fixable Viability Dye (eBioscience). For cytokine staining, cells were incubated for 4 hr at 37°in the presence of PMA, ionophore and Brefeldin A as described elsewhere, 18 and stained with antibodies against IL-2 (JES6-5H4), IL-5 (TRFK5), IL-13 (13A), IL-17 (17B7) or interferon-c (2E2). All flow cytometry experiments were acquired using a BD LSR II cytometer or LSR Fortessa (BD). FLOWJO Version 8.8.7 was used for data analysis. For calculating total cell numbers, cell concentrations were counted with a CASY cell counter (Roche, Basel, Switzerland) and the total numbers multiplied by the frequency of CD4 + Foxp3 + cells among living cells.
Treg cell culture
Flat-bottom 96-well plates were pre-coated with 5 lg/purified anti-mouse CD3e (145-2C11, Biolegend) at 37°for a minimum of 30 
Statistical analysis
Statistical analysis was performed using GRAPHPAD PRISM using a two-tailed unpaired Student's t-test when only two groups were tested, or analysis of variance with Bonferroni-Post-test where more than two groups were tested. Differences were considered statistically significant when P < 0Á05. Bars represent arithmetic mean except for bars in graphs with a logarithmic y-axis, which represent the median. For the analysis of genes altered in the intestinal cadherin switch model, GSE81920 was analysed using the Multiplot module from GENEPATTERN. 22 Genes with cytokine activity were identified with AmiGO Gene Ontology term GO:0005125, Mus musculus. (Fig. 1a) . The frequency of IL-2 + CD4 + T cells was also not increased in the gut from Cdh1 DIEC mice; actually, the frequency of IL-2-expressing CD4 + T cells was reduced compared with controls in the gut, but not in lymphoid organs (Fig. 1a , and see Supplementary material, Fig. S1 ). In contrast, when we examined the Foxp3 + T-cell (Treg) compartment in Cdh1 DIEC mice, we found a striking increase in the frequency of Treg cells in the small intestine and colon, with a smaller accumulation in spleen and mesenteric lymph nodes (Fig. 1b) . Neither the co-expression of E-cadherin and N-cadherin (Cdh1 fl/Ncad mice) nor 14 Their smaller spleen size, which corresponds with their smaller body size (manuscript in preparation), probably explains the lower cell numbers and total Treg cell numbers observed in the spleen from Cdh1 DIEC mice (Fig. 1b) Each point corresponds to an individual mouse; 8-week-old IL-10-deficient mice (two females, one male) and sex-matched heterozygous littermates were used. ***P < 0Á001; ns, not significant compared to controls.
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Results
Ablation
Effector Treg cells have been further divided into subpopulations expressing transcription factors mirroring the other CD4 + T helper subsets, such as T-bet, GATA3 and RORct. 6, 8 The expression of the transcription factor GATA3 in intestinal Treg cells was mostly restricted to KLRG1 + cells in Cdh1 DIEC and control mice (Fig. 3d,e) , whereas we did not find a correlation of the transcription factors T-bet and RORct with KLRG1 expression in Treg cells (Fig. 3d,e 15, 16 Upon recombination, a stable form of b-catenin is generated that can signal in the absence of Wnt ligands, and the progeny of the recombined intestinal stem cells therefore exhibits constitutive b-catenin signalling.
We analysed the mice 3 weeks after the tamoxifen injection, when active b-catenin accumulates in the nucleus. We found that enhanced b-catenin signals increased Treg cell accumulation in the small intestine of adult mice (Fig. 4a) , and also increased the accumulation of KLRG1 + Treg cells (Fig. 4b) . Indeed, the increased Treg cell frequency was due to an augmentation in KLRG1 + Foxp3 + T cells, whereas no differences were seen in the proportions of KRLG1 À Foxp3 + cells (Fig. 4c,d ), similar to the pattern observed in mice with epitheliumspecific cadherin switch. In keeping with the published regional variations of b-catenin activation, 16 KLRG1 + Treg cell accumulation was more marked in the small intestine compared with the colon. As in Cdh1 DIEC mice, the KLRG1 + Treg cells were GATA3 + (Fig. 4e) 34 On the other hand, Treg cells accumulate in many types of tumours, where they can suppress the cytotoxic antitumoral response. 6, 35 To assess whether KLRG1 + Treg cells are also specifically increased in a model of spontaneous gut tumour development with enhanced b-catenin signalling, we analysed the Treg populations in intestinal tumours from APC min/+ mice. 36 These mice have a heterozygous mutation in Apc, a gene encoding an essential protein to target bcatenin for proteosomal degradation that is mutated in around 80-90% of human colorectal cancer tumours. 37 Upon spontaneous mutations in the second Apc allele, b-catenin is stabilized and aging APC min/+ mice therefore spontaneously develop intestinal tumours, primarily in the small intestine (reviewed in ref. 38 ). It has been previously shown that Treg cells accumulate in these tumours and impair cytotoxic responses. 39 In accordance with published data, we found that most tumours had increased Treg cell frequencies (Fig. 5a ). When we analysed KLRG1 expression in these mice, we found that KLRG1 + GATA3 + Treg cells were predominant among Treg cells from the tumours, but not from the surrounding tissue (Fig. 5b,c) . As in mice with cadherin switch or with an epithelial-specific increase in b-catenin, the increased Treg cell frequency in intestinal tumours from APC min/+ mice was exclusively due to an increase in the KLRG1 + Treg cell population (Fig. 5d,e) . In accordance with the other models with increased b-catenin signals, the frequency of KLRG1 (Fig. 6a) . Interleukin-33 is known to be upregulated in APC min tumours, 20 and we found that increased b-catenin signals also promote IL-33 induction in the intestinal epithelium (Fig. 6b,c) . Hence, IL-33 is induced in epithelial cells with activated b-catenin.
Interleukin-33 promotes the accumulation of GATA3 + Treg cells in the intestine, 40 and KLRG1 + Treg cells express high levels of the IL-33 receptor upon stimulation (Fig. 6d) . Accordingly, IL-33 induced the accumulation of KLRG1 + Treg cells in vitro (Fig. 6e) . The accumulation was due to the expansion of existing KLRG1 + Treg cells, as IL-33 did not induce KLRG1 expression on KLRG1 À Treg cells upon culture (Fig. 6f) . Interleukin-33 favoured KLRG1 + Treg cell division as well as accumulation of undivided cells (Fig. 6g) , indicating that it can enhance both proliferation and survival of KLRG1 + Treg cells. Hence, our data indicate that IL-33 can link malignancyassociated epithelial changes to the accumulation of a specific Treg cell subset in mouse intestine.
Discussion
Treg cells in the gut are controlled by local factors, 8 but the role of epithelial cells in this cross-talk, and how tumoral changes affect intestinal Treg cells, is less well understood. Our results indicate that changes associated with tumour progression, namely cadherin switching and increased b-catenin activity, cause effector Treg cell accumulation in the gut.
Beyond their functions in cell-cell adhesion, cadherins also affect intracellular signals. E-cadherin directly binds the Wnt pathway mediator b-catenin, and a previous report showed that b-catenin transcriptional targets are increased in our model of intestinal cadherin switch.
14 Using a model of induced epithelial b-catenin signalling, 16 20 and that it directly promotes KLRG1 + Treg cell survival and proliferation. It will be of interest to assess the levels of IL-33 in different models of intestinal inflammation, such as Th2-driven models or in the DSS model, and to check its effect on KLRG1 + Treg cell accumulation in these settings. Whether b-catenin directly induces IL-33, or whether the increase in IL-33 is secondary to changes induced by b-catenin signalling, remains to be investigated.
Cadherin switch, b-catenin signals, and Treg cell accumulation are all linked to cancer. Treg cells often accumulate in human and mouse tumours, and they are considered to contribute to the immunosuppressive environment that protects tumours from immune attack. Indeed, in human colorectal cancer effector Treg cell accumulation is associated with a worse disease-free outcome. 11 Here we show that Treg cell accumulation in spontaneous tumours in the APC min/+ model, which is known to inhibit the accumulation of effector T cells, 39 is exclusively due to KLRG1 + GATA3 + Treg cells. We do ***P < 0Á001; **P < 0Á01; ns, not significant. individual mouse, a total of seven control and nine APC min/+ mice were used. Mice were 18-21 weeks old when analysed. Mice from both sexes were used for this study. Small intestinal tumours with a diameter between 1 and 4 mm were analysed ***P < 0Á001; *P < 0Á05; ns, not significant. to activate transforming growth factor-b, 45 which also favours the oncogenic process. It will be of interest to check whether Treg cells equivalent to mouse KLRG1 + GATA3 + Treg cells accumulate in human tumours. Because IL-33 is an alarmin expressed by different tissues, 46 the processes described here may play a role in tuning immune regulation in tumours from various organs.
Our results show that increased b-catenin signals promote accumulation of KLRG1 + Treg cells, resulting in a strong increase in Foxp3 + frequencies. Our present findings complement reports on the regulation of tissue repair by KLRG1 + Treg cells, 42, 43 stressing the bidirectional interaction between the immune system and epithelia, and highlight an unappreciated role for intestinal epithelial cells in controlling the size of the gut Treg cell compartment. This may be important to ensure that protective immunity against invading pathogens is retained. Tumour-associated epithelial changes disrupt this process, which results in the local accumulation of a specific effector Treg cell subset, underscoring how epithelial cells are important for the maintenance of a balance among CD4 + T-cell populations in the gut. Furthermore, our findings provide mechanistic insight into how the accumulation of immunosuppressive effector Treg populations is mediated following epithelial changes. Given the enormous clinical utility of strategies that target pathways inhibiting intratumoral immune responses, our data identify a novel target that could potentially be manipulated to inhibit Treg cell accumulation in tumours with fewer of the deleterious side effects associated with current frontline therapeutics. Fig. 1(d) . Figure S2 . 
